BCM
NUTX

Bayesian Capital Management’s Nutex Health NUTX Stock Holding History

Bayesian Capital Management’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-78
Closed -$11.8K – 983
2023
Q1 		$11.8K Hold
78
– – ﹤0.01% 741
2022
Q4 		$22.2K Buy
+78
New +$15K ﹤0.01% 729

Other funds holding NUTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BHWM
Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Bayesian Capital Management's NUTX Position: Q2 2023 in Review

Bayesian Capital Management sold out of Nutex Health (NUTX) in Q2 2023, closing a stake of 78 shares — an estimated $11.8K sold.

Bayesian Capital Management first reported a position in NUTX in Q4 2022 and held it in 2 quarters. The position peaked at $22.2K in Q4 2022. 74 funds tracked by Wall St. Rank hold NUTX as of Q2 2023.

  • Bayesian Capital Management reported no remaining Nutex Health position as of Q2 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 78 Nutex Health shares in Q2 2023, an estimated $11.8K.
  • Bayesian Capital Management first reported a position in Nutex Health in Q4 2022 and held it in 2 quarters.
  • Bayesian Capital Management's Nutex Health position peaked at $22.2K in Q4 2022.
  • 74 funds tracked by Wall St. Rank held Nutex Health as of Q2 2023.

Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.